QIAGEN HEALTHCARE BIOTECHNOLOGIES LIMITED

Company number 11561466

Date	Type	Description	View / Download
06 Dec 2023	AA	Micro company accounts made up to 9 March 2023	(3 pages) Download iXBRL
17 Oct 2023	CS01	Confirmation statement made on 9 September 2023 with no updates	(3 pages)
30 Nov 2022	DISS40	Compulsory strike-off action has been discontinued	(1 page)
29 Nov 2022	GAZ1	First Gazette notice for compulsory strike-off	(1 page)
25 Nov 2022	AA	Unaudited abridged accounts made up to 9 March 2022	(9 pages) Download iXBRL
23 Nov 2022	CS01	Confirmation statement made on 9 September 2022 with no updates	(3 pages)
11 May 2022	DISS40	Compulsory strike-off action has been discontinued	(1 page)
10 May 2022	GAZ1	First Gazette notice for compulsory strike-off	(1 page)
05 May 2022	AA	Total exemption full accounts made up to 9 March 2021	(12 pages)
02 Feb 2022	TM01	Termination of appointment of Peer Michael Shatz as a director on 2 February 2022	(1 page)
06 Dec 2021	CS01	Confirmation statement made on 9 September 2021 with updates	(4 pages)
19 Nov 2021	AD01	Registered office address changed from , Citylabs 2.0 Hathersage Road, Manchester, M13 0JH, England to Citylabs 2.0 Hathersage Road Manchester M13 0BH on 19 November 2021	(1 page)
28 Sep 2021	AD01	Registered office address changed from , Skelton House Lloyd Street North, Manchester, M15 6SH, United Kingdom to Citylabs 2.0 Hathersage Road Manchester M13 0BH on 28 September 2021	(1 page)
26 Apr 2021	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 09/03/20	(1 page)
25 Nov 2020	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 09/03/20	(166 pages)
18 Nov 2020	AA	Total exemption full accounts made up to 9 March 2020	(13 pages) Download iXBRL
22 Sep 2020	CS01	Confirmation statement made on 9 September 2020 with no updates	(3 pages)
18 Aug 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 09/03/20	(3 pages)
26 Nov 2019	AA01	Current accounting period extended from 30 September 2019 to 9 March 2020	(1 page)
20 Sep 2019	CS01	Confirmation statement made on 9 September 2019 with updates	(4 pages)
20 Sep 2019	CH01	Director's details changed for Peer Michael Shatz on 30 August 2019	(2 pages)
09 Sep 2019	AP01	Appointment of Richard Powell Price as a director on 30 August 2019	(2 pages)
06 Sep 2019	PSC02	Notification of Qiagen N.V. as a person with significant control on 30 August 2019	(2 pages)
06 Sep 2019	PSC07	Cessation of Ge Healthcare Limited as a person with significant control on 30 August 2019	(1 page)
06 Sep 2019	AP01	Appointment of Axel Backheuer as a director on 30 August 2019	(2 pages)